Farther Finance Advisors’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53 Buy
+8
New +$54 ﹤0.01% 5850

Other funds holding GYRE

Farther Finance Advisors's GYRE Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Gyre Therapeutics (GYRE) in Q2 2026: 8 shares worth $53. The stake represents ﹤0.01% of the portfolio and ranks #5850 among its holdings.

4 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Farther Finance Advisors held 8 shares of Gyre Therapeutics worth $53 as of Q2 2026.
  • Gyre Therapeutics was a new Farther Finance Advisors position in Q2 2026.
  • Gyre Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5850 holding.
  • 4 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.